PUBLIC COMPANY
save$STROSUTRO BIOPHARMA, INC.
$STROSouth San Francisco, CA, USupdated 15d ago
Sutro Biopharma, Inc. is a publicly traded biotechnology company headquartered in South San Francisco, California focused on clinical-stage drug discovery, development and manufacturing. Using a proprietary cell-free protein synthesis platform, Sutro is working on oncology therapeutics using protein engineering and rational design. Founded in 2003 under the name Fundamental Applied Biology, the company name changed to Sutro Biopharma in 2009. William Newell, CEO as of 2024, joined Sutro in January 2009.
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 1
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase1A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
- phase3REFRaME-O1: A Study to Investigate the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Choice (IC) Chemotherapy in Women With Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing FOLR1
- phase1A Study of STRO-002, an Anti-Folate Receptor Alpha Antibody Drug Conjugate, in Combination With Bevacizumab in Epithelial Ovarian Cancer
- phase2Luveltamab Tazevibulin (STRO-002) in Infants and Children < 12 Years of Age With Relapsed/Refractory CBFA2T3::GLIS2 AML
- phase2Study to Investigate Luveltamab Tazevibulin in Adults With Advanced or Metastatic Non-small Cell Lung Cancer
- phase1Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial Cancers
- phase1Study of STRO-001, an Anti-CD74 Antibody Drug Conjugate, in Patients With Advanced B-Cell Malignancies
Insider activity
source: SEC Form 4routine RSU / option mechanics (6)
- Mar 4, 26tax coverChung Jane · Chief Executive Officer282 sh
- Mar 4, 26tax coverPauling David · Chief Admin. Ofcr. & GC277 sh
- Mar 4, 26option exerciseChung Jane · Chief Executive Officer788 sh
- Mar 4, 26option exercisePauling David · Chief Admin. Ofcr. & GC675 sh
- Mar 4, 26option exercisePauling David · Chief Admin. Ofcr. & GC675 sh
- Mar 4, 26option exerciseChung Jane · Chief Executive Officer788 sh
🐶 Hiring Signal
News
- Nonprofit buys experimental cancer drug to maintain patient accessIn a rare move, nonprofit organization Blood Cancer United is buying the remaining supplies of a discontinued investigational cancer drug.stat · 2mo ago
Data sources
last refreshed 7m ago
Found something off?
comments(0)
5-min edit window · permanent after that